The global liposome drug delivery market size is expected to be worth USD 5.59 billion in 2024 and is anticipated to reach around USD 13.12 billion by 2034, growing at a CAGR of 8.91% over the forecast period 2024 to 2034. The rising healthcare infrastructure and the increasing use of liposome drug delivery method in the various disease such as cancer, skin infraction and other infectious disease are driving the growth of the market.
The global ophthalmic viscosurgical devices (OVD) market size is expected to be worth USD 543.28 million in 2024 and is anticipated to reach around USD 806.50 million by 2034, growing at a solid CAGR of 4.03% over the forecast period 2024 to 2034.The ophthalmic viscosurgical devices (OVD) market is driven by the advancement of cutting-edge surgical procedures, including advanced vitreoretinal surgery and femtosecond laser cataract surgery, drives the need for OVDs with qualities. To ensure the best possible surgical results, these devices must be specifically designed to fulfill the demands of these specific procedures.
The global cancer IVD market size is expected to be worth USD 19.45 billion in 2024 and is anticipated to reach around USD 34.97 billion by 2034, growing at a solid CAGR of 6.04% over the forecast period 2024 to 2034. The North America cancer IVD market size reached USD 6.60 billion in 2023. The rising cancer incidences, advancement of technologies, enhancement in the healthcare sector, and increased awareness among patients drive the market growth.
The global veterinary Imaging market size is expected to be worth USD 1.96 billion in 2024 and is anticipated to reach around USD 3.86 billion by 2034, growing at a CAGR of 7.02% over the forecast period 2024 to 2034.
The global sterility indicators market size is expected to worth USD 1.24 billion in 2024 and is anticipated to reach around USD 4.02 billion by 2034, growing at a solid CAGR of 12.51% over the forecast period 2024 to 2034. The North America sterility indicators market size reached USD 390 million in 2023. The sterility indicators market is increasing due to enhancements in healthcare organizations, the growth and development of the medical device industry, increased awareness for infection control, and government regulations.
The global neonatal ventilators market size is expected to worth USD 457.84 million in 2024 and is anticipated to reach around USD 910.80 million by 2034, growing at a CAGR of 7.12% over the forecast period 2024 to 2034.
The global intrauterine devices market size is expected to be worth USD 6.48 billion in 2024 and is anticipated to reach around USD 9.29 billion by 2034, growing at a CAGR of 3.67% over the forecast period 2024 to 2034.
The global mice model market size is expected to be valued at USD 10.78 billion in 2024 and is anticipated to reach around USD 19.36 billion by 2034, expanding at a solid CAGR of 6.03% over the forecast period 2024 to 2034. The North America mice model market size reached USD 8.24 billion in 2023. The increasing gene editing tools advancements, increased humanized mice model demands, human and mice physiological similarities, increasing personalized medicine consumption in developed and developing countries, etc. contribute to the growth of the market.
The global atrial fibrillation drugs market size is expected to be valued at USD 15.59 billion in 2024 and is anticipated to reach around USD 20.99 billion by 2034, expanding at a solid CAGR of 3.02% over the forecast period 2024 to 2034. The North America atrial fibrillation drugs market size reached USD 25.88 billion in 2023. The increasing demand is due to high incidences of AF, a growing population of elderly, an improved health care system, and better diagnosis and management of the disease are driving the atrial fibrillation drugs market.
The global Biologics CDMO market size is expected to be worth USD 21.96 billion in 2024 and is anticipated to reach around USD 92.37 billion by 2034, growing at a solid CAGR of 15.45% over the forecast period 2024 to 2034.
The global pressure monitoring market size is projected to be worth around USD 28.69 billion by 2034 from USD 12.78 billion in 2024, at a CAGR of 8.42% from 2024 to 2034. The rising prevalence of chronic diseases, such as hypertension and cardiovascular diseases, is the key factor driving pressure monitoring market growth. The increasing population of senior people can fuel market growth further.
The global medical gas equipment market size is anticipated to reach around USD 5.94 billion by 2034 from USD 2.79 billion in 2024, at a CAGR of 7.83% from 2024 to 2034. The North America medical gas equipment market size reached USD 1.11 billion in 2023. The benefits of medical gas equipment include environmental considerations, compliance with standards, patient comfort, space utilization, cost-effectiveness, convenience and efficiency, safety, etc., contributing to the growth of the market.
The global medical health screening market size is projected to be worth around USD 48.07 billion by 2034 from USD 28.09 billion in 2024, at a CAGR of 5.52% from 2024 to 2034. The North America medical health screening market size reached USD 9.58 billion in 2023. The rising health geriatric population is contributing to the medical health screening market growth.
The U.S. ambulatory surgical center market size is projected to be reach around USD 55.75 billion by 2033 from USD 41.13 billion in 2024, at a CAGR of 3% from 2024 to 2033. The U.S. ambulatory surgical center market is driven by the surgery moving from hospitals to these facilities.
The global lung stent market size is projected to be worth around USD 629.72 million by 2034 from USD 211.46 million in 2024, at a CAGR of 11.53% from 2024 to 2034. The North America lung stent market size reached USD 92.90 million in 2023 The rising investment by private and public organizations for the development of the non-vascular stent is driving the growth of the market. The growing number of lung-related disorders is increasing the demand for lung stents.
The global left atrial appendage closure devices market size is projected to be worth around USD 7.01 billion by 2034 from USD 1.87 billion in 2024, at a CAGR of 14.12% from 2024 to 2034. The North America left atrial appendage closure devices market size reached USD 720 million in 2023. The rising prevalence of atrial fibrillation and rising government initiatives contribute to the growth of the market. The growing technological advancement is also promoting the growth of the market.
The global in-vitro colorectal cancer screening tests market size is projected to be worth around USD 1,310 million by 2034 from USD 970 million in 2024, at a CAGR of 3.06% from 2024 to 2034. The North America in-vitro colorectal cancer screening tests market size reached USD 410 million in 2023. The in-vitro colorectal cancer screening tests market growth is attributed to the increasing incidence of colorectal cancer.
The global health intelligent virtual assistant market size is projected to be worth around USD 4,680.01 million by 2034 from USD 513.91 million in 2024, at a CAGR of 24.72% from 2024 to 2034. The North America health intelligent virtual assistant market size reached USD 160.70 million in 2023. Organizations are also adopting technologies that help ensure a smooth patient experience. These advancements are crucial in enhancing the interaction between professionals and patients.
The global surrogacy market size is projected to be worth around USD 195.97 billion by 2034 from USD 21.85 billion in 2024, at a CAGR of 24.53% from 2024 to 2034. The surrogacy market is driven by the growing rates of infertility. With many couples finding it difficult to conceive naturally, surrogacy is a potential option. Several factors, including delayed childbirth, lifestyle decisions, and health issues influence this tendency. Surrogacy drives the market in certain areas since it provides surrogate mothers with a sizable cash opportunity.
The global mobile pet care market size is projected to be worth around USD 1,625.4 million by 2034 from USD 749.40 million in 2024, at a CAGR of 8.05% from 2024 to 2034. A rise in pet adoption and humanization and increased consumer spending on pet care and grooming are driving growth in the mobile pet care market.
The global artificial organs and bionics market size is projected to be worth around USD 100.31 billion by 2034 from USD 41.15 billion in 2024, at a CAGR of 9.32% from 2024 to 2034. The North America artificial organs and bionics market size reached USD 17.69 billion in 2023. The key drivers of the artificial organs and bionics market are the increasing number of transplants and the rising number of people waiting for donors.
The global pharmaceutical cold chain packaging market size is projected to be worth around USD 69.55 billion by 2034 from USD 17.46 billion in 2024, at a CAGR of 14.82% from 2024 to 2034. The North America pharmaceutical cold chain packaging market size reached USD 5.17 billion in 2023. Strong cold chain packaging solutions are required to preserve product efficacy due to the increase in the manufacture and distribution of biologics and vaccines that are temperature sensitive. This drives the growth of the pharmaceutical cold chain packaging market.
The global sexual wellness products market size is projected to be worth around USD 52.71 billion by 2034 from USD 25.29 billion in 2024, at a CAGR of 7.62% from 2024 to 2034. The rising development in the healthcare sector is driving the market growth. Also, the growing infertility issue among couples has contributed to the market growth. Additionally, advancements in medical technology have driven the growth of the sexual wellness products market.
The global lacrimal devices market size is projected to be worth around USD 238.24 million by 2034 from USD 165.19 million in 2024, at a CAGR of 3.73% from 2024 to 2034. The North America lacrimal devices market size reached USD 57.33 million in 2023. increasing prevalence of eye disorders, easy procedures for lacrimal treatment, and advanced technologies in lacrimal devices contribute to the growth of the market.
The global lyophilization equipment market size is projected to be worth around USD 19.53 billion by 2034 from USD 7.94 billion in 2024, at a CAGR of 9.44% from 2024 to 2034. The North America lyophilization equipment market size reached USD 2.54 billion in 2023. The lyophilization equipment market helps in various industries like biomedical, biotechnology, pharmaceutical, and food processing for various applications. It helps to reduce sample contamination risks, increases reliability and robustness, and simplifies assay setup.
The global healthcare IT outsourcing market size is projected to be worth around USD 150.13 billion by 2034 from USD 74.14 billion in 2024, at a CAGR of 7.31% from 2024 to 2034. The North America healthcare IT outsourcing market size reached USD 39.38 billion in 2023. Increasing digitalization across healthcare system resulting into the need to manage vast amount of data so that to focus on core functionalities like patient centric management are the driving factors for healthcare IT outsourcing market.
The global anti-obesity drugs market size is projected to be worth around USD 55.25 billion by 2034 from USD 5.69 billion in 2024, at a CAGR of 5.53% from 2024 to 2034. The North America anti-obesity drugs market size reached USD 3.04 billion in 2023. The increase in the incidence of obesity has led to a large patient population suffering from debilitating problems, which is the key factor driving the anti-obesity drugs market growth.
The global computer vision in healthcare market size is projected to be worth around USD 53.01 billion by 2034 from USD 2.60 billion in 2024, at a CAGR of 35.21% from 2024 to 2034. The North America computer vision in healthcare market size reached USD 710 million in 2023. Increasing demand for personalized treatments is driving the growth of computer vision in healthcare market.
The global coronary artery bypass graft market size is projected to be worth around USD 35.17 billion by 2034 from USD 14.28 billion in 2024, at a CAGR of 9.43% from 2024 to 2034. The need for the coronary artery bypass graft market is driven by the rise in cardiovascular illnesses worldwide, which frequently necessitate surgical intervention.
The North America diabetic foot ulcer treatment market size is projected to be worth around USD 5.56 billion by 2034 from USD 3.15 billion in 2024, at a CAGR of 5.86% from 2024 to 2034. The rising cases of diabetes, and advanced research and development drive the North America diabetic foot ulcer treatment market. Alongside, the well-established healthcare infrastructure is observed to promote the market’s expansion in the upcoming years.
The global laboratory temperature control units market size is projected to be worth around USD 1,181.90 million by 2034 from USD 657.48 million in 2024, at a CAGR of 6.04% from 2024 to 2034. The increasing research and development activities worldwide contribute to the growth of the market. The growing prevalence of chronic conditions pushes the key players and government institutions to conduct R&D.
The global cell analysis market size is projected to be worth around USD 84.01 billion by 2034 from USD 32.95 billion in 2024, at a CAGR of 9.81% from 2024 to 2034. The growing prevalence of rare diseases around the world has driven the growth of the cell analysis market. Also, the rising number of cloud-based cell analysis services boosts industrial growth. Moreover, the rise in the number of hospitals and clinical settings contributes positively to the market.
The global organ care products market size is projected to be worth around USD 757.90 million by 2034 from USD 174.19 million in 2024, at a CAGR of 15.84% from 2024 to 2034. The North America organ care products market size reached USD 84.21 million in 2023. The rising incidence of organ failure among adults contributes to market growth. Rising awareness about organ donation across the globe is also observed to support the market’s expansion in the upcoming years.
The global pharmaceutical analytical testing market size is projected to be worth around USD 21 billion by 2034 from USD 8.37 billion in 2024, at a CAGR of 8.72% from 2024 to 2034. The North America pharmaceutical analytical testing market size reached USD 3.26 billion in 2023. The pharmaceutical analytical testing market is driven by the major factors such as rising investments in the pharmaceutical industry and booming government support for the same. Alongside, major players are involved in creating sophisticated and advanced testing materials, these factors along with technological innovations will support the market’s growth.
The global medical radiation shielding market size is projected to be worth around USD 3.08 billion by 2034 from USD 1.61 billion in 2024, at a CAGR of 6.7% from 2024 to 2034. The North America medical radiation shielding market size reached USD 570 million in 2023. The medical radiation shielding market is driven by rising investments in the healthcare infrastructure, especially by developing countries such as Asian countries. Additionally, integration of advanced technologies in the market creates potential for the market to grow.
The global disposable surgical devices market size is projected to be worth around USD 13.90 billion by 2034 from USD 6.31 billion in 2024, at a CAGR of 8.22% from 2024 to 2034. The North America disposable surgical devices market size reached USD 1.98 billion in 2023.The disposable surgical devices market is driven by the rising rates of chronic illness.
The global RTLS healthcare market size is projected to be worth around USD 16.02 billion by 2034 from USD 2.88 billion in 2024, at a CAGR of 18.70% from 2024 to 2034. The benefits of RTLS healthcare include increased healthcare quality, reduced expenses by preventive maintenance, improved patient experience, etc. contributing to the growth of the market.
The global vascular access devices market size is projected to be worth around USD 3.36 billion by 2034 from USD 2.02 billion in 2024, at a CAGR of 5.22% from 2024 to 2034. The North America vascular access devices market size reached USD 1.13 billion in 2023. The rising population and the increasing demand for healthcare infrastructure are driving the growth of the market. Sealants
The global stem cell manufacturing market size is projected to be worth around USD 41.45 billion by 2034 from USD 14.18 billion in 2024, at a CAGR of 11.32% from 2024 to 2034. The North America stem cell manufacturing market size reached USD 4.97 billion in 2023. The stem cell manufacturing market is driven by the increasing prevalence of long-term illnesses like diabetes, cancer, and neurological conditions. It is the main factor propelling the market for stem cell production. Promising therapy options for various diseases are provided by stem cell-based therapies, which drive demand for their development and manufacture.
The global angioplasty balloons market size is projected to be worth around USD 3.86 billion by 2034 from USD 2.63 billion in 2024, at a CAGR of 3.92% from 2024 to 2034. The North America angioplasty balloons market size reached USD 1.04 billion in 2023. The increasing prevalence of cardiovascular diseases across the world driving the growth of the market.
The global biochips market size is projected to be worth around USD 41.90 billion by 2034 from USD 12.71 billion in 2024, at a CAGR of 12.67% from 2024 to 2034. The North America biochips market size reached USD 5.53 billion in 2023. The biochips market growth is attributed to increased application in various healthcare settings.
The global clinical risk grouping solution market size is projected to be worth around USD 2,267.76 million by 2034 from USD 760.84 million in 2024, at a CAGR of 11.54% from 2024 to 2034. The North America clinical risk grouping solution market size reached USD 320.60 million in 2023. A global increase in healthcare expenditure due to a rising prevalence of chronic diseases like cancer, diabetes, and cardiovascular conditions and the availability of data due to increased digitization in the healthcare industry is fueling growth in the clinical risk grouping solution market.
The global artificial blood vessels market size is projected to be worth around USD 3.75 billion by 2034 from USD 2.23 billion in 2024, at a CAGR of 5.33% from 2024 to 2034. The demand for the artificial blood vessels market is primarily being boosted by the rising prevalence of various cardiovascular diseases coupled with a rapidly growing geriatric population.
The global neuroprosthetics market size is projected to be worth around USD 62.98 billion by 2034 from USD 14.75 billion in 2024, at a CAGR of 15.62% from 2024 to 2034. The neuroprosthetics market is expanding due to advancements in brain-computer interface technology and increasing demand for enhanced prosthetic functionality.
The global animal growth promoters and performance enhancers market size is predicted to reach around USD 27.63 billion by 2034 from USD 15.68 billion in 2024, at a CAGR of 5.83% from 2024 to 2034. The North America animal growth promoters and performance enhancers market size reached USD 6.37 billion in 2023. The animal growth promoters and performance enhancers market are driven by the animal disease prevalence and antibiotic resistance.
The global in vivo CRO market size is projected to be worth around USD 10.89 billion by 2034 from USD 4.99 billion in 2024, at a CAGR of 8.11% from 2024 to 2034. The North America in vivo CRO market size reached USD 2.36 billion in 2023. The rising demand for the clinical research outsourcing is driving the growth of the market.
The global prostate cancer diagnostics market size is projected to be worth around USD 17.01 billion by 2034 from USD 9.13 billion in 2024, at a CAGR of 6.42% from 2024 to 2034. The increasing cases of transitional cell (or urothelial) cancer across the world are driving the growth of the prostate cancer diagnostics market.
The global automated sample storage systems market size is projected to reach around USD 3.54 billion by 2034 from USD 1.22 billion in 2024, at a CAGR of 11.21% from 2024 to 2034. The North America automated sample storage systems market size reached USD 420 million in 2023. The automated sample storage systems' benefits include helping to maximize sample accessibility and integrity, strong refrigeration designed for the protection of samples from disasters, and automated handling helps to improve sample protection and minimize sample temperature cycling.
The global inhalation and nasal spray generic drugs market size is projected to surpass around USD 54.44 billion by 2034 from USD 23.06 billion in 2024, at a CAGR of 8.97% between 2024 and 2034. The North America interleukin inhibitors market size reached USD 8.04 billion in 2023. The rising cases of chronic respiratory illness worldwide are driving the growth of the market.
The global hospital emergency department market size is predicted to reach around USD 211.03 billion by 2034 from USD 140.79 billion in 2024, at a CAGR of 4.13% between 2024 and 2034. Hospital emergency departments help in emergency care, which saves lives by providing swift and quality medical care; skilled staff help to assess the situation, diagnosis, and stabilization. These factors help to the growth of the market.
The global interleukin inhibitors market size is projected to reach around USD 85.18 billion by 2034 from USD 27.33 billion in 2024, at a CAGR of 12.04% between 2024 and 2034. The North America interleukin inhibitors market size reached USD 17.56 billion in 2023. The growing cases of hypereosinophilic syndrome across the world are driving the growth of the interleukin inhibitors market.
The global cancer immunotherapy drug discovery outsourcing market size is predicted to be worth around USD 3.87 billion by 2034 from USD 1.52 billion in 2024, at a CAGR of 9.83% between 2024 and 2034. The North America cancer immunotherapy drug discovery outsourcing market size reached USD 520 million in 2023. Cancer immunotherapy drug discovery outsourcing helps to make it easier for it to find and remove cancer cells or help the immune system work harder. Many immunotherapy drugs help to fight cancer which helps to the growth of the market.
The global pediatric asthma treatment market size is projected to reach around USD 16.08 billion in 2034 from USD 12.07 billion in 2024, at a CAGR of 2.91% between 2024 and 2034. The worldwide pediatric asthma treatment market is driven by growth in the incidence of asthma and an increase in allergy cases.
The global cell and gene therapy bioanalytical testing services market size is projected to reach around USD 1,113.86 million in 2034 from USD 548.55 million in 2024, at a CAGR of 7.34% between 2024 and 2034. The North America cell and gene therapy bioanalytical testing services market size reached USD 209.53 million in 2023.
The global breath analyzers market size is expected to be worth around USD 17.87 billion in 2034 from USD 3.84 billion in 2024, at a CAGR of 16.63% between 2024 and 2034. The North America breath analyzers market size reached USD 1.48 billion in 2023. The breath analyzers market demand is driven by rising legal awareness and enforcement of alcohol and drug addiction legislation.
The global orthopedic contract manufacturing market size is expected to be valued at USD 8.39 billion in 2024 and is anticipated to reach around USD 17.67 billion by 2034, expanding at a solid CAGR of 7.73% over the forecast period from 2024 to 2034. The North America orthopedic contract manufacturing market size reached USD 2.88 billion in 2023. Innovations in technology, rising incidence of orthopedic disorders, increased orthopedic surgeries, and cost efficiencies associated with outsourcing are a few of the factors driving the orthopedic contract manufacturing market growth.
The global cell and gene therapy manufacturing market size is expected to be valued at USD 11.60 billion in 2024 and is anticipated to reach around USD 122.86 billion by 2034, expanding at a solid CAGR of 26.62% over the forecast period from 2024 to 2034. The North America cell and gene therapy manufacturing market size reached USD 4.40 billion in 2023.
The global orthobiologics market size is calculated at USD 6.99 billion in 2024 and is expected to reach around USD 11.95 billion by 2034, expanding at a solid CAGR of 5.52% over the forecast period 2024 to 2034. The increasing prevalence of orthopedic procedures coupled with the growing geriatric population is the major factor fostering the orthobiologics market growth. Orthobiologics, also known as regenerative cellular therapies, encompass products that contain or secrete growth factors to aid tissue healing, alleviate pain, and restore normal function. Various orthobiologics available in the market operate through different mechanisms. Autologous orthobiologics are derived from the patient's own body, where, under suitable conditions, they divide to form precursor cells. These products are utilized in treating conditions like fracture recovery and spinal fusion and are available for various body parts, including the hip, knee, ankle, spine, and wrist. Orthobiologics primarily facilitates faster injury healing.
The global chemotherapy market size is estimated to be valued at 9.53 billion in 2024 and is predicted to reach around USD 19.69 billion by 2034, expanding at a CAGR of 7.53% from 2024 to 2034. The North America chemotherapy market size reached USD 3.90 billion in 2023. The market for cancer chemotherapy is anticipated to expand due to advances in drug delivery and development and the shift toward biologics.
The global sepsis therapeutics market size is expected to be valued at USD 3.72 billion in 2024 and is predicted to reach around USD 7.36 billion by 2034, expanding at a CAGR of 7.05% from 2024 to 2034. The North America sepsis therapeutics market size reached USD 1.18 billion in 2023. The benefits of sepsis therapeutics include supportive care that includes oxygen, different medicines like antibiotics, vitamins, sedatives, and anti-inflammatory drugs used for the treatment of sepsis and septic shock, and surgery that helps to remove infection sources like dead or infected tissue and pus.
The global animal biotechnology market size was USD 26.49 billion in 2023, calculated at USD 28.93 billion in 2024 and is expected to reach around USD 69.88 billion by 2034. The market is expanding at a solid CAGR of 9.22% over the forecast period 2024 to 2034. The North America animal biotechnology market size reached USD 9.01 billion in 2023. The animal biotechnology market is driven by the frequency and intricacy of animal illnesses rising.
The global digital pathology market size was USD 1.10 billion in 2023, calculated at USD 1.19 billion in 2024 and is expected to reach around USD 2.58 billion by 2034, expanding at a CAGR of 8.05% from 2024 to 2034. The North America digital pathology market size reached USD 450 million in 2023. The growing prevalence of chronic disorders drives the market’s growth.
The global ePrescribing market size was USD 3.72 billion in 2023, calculated at USD 4.71billion in 2024 and is expected to reach around USD 50.71 billion by 2034. The market is expanding at a solid CAGR of 26.82% over the forecast period 2024 to 2034. The North America ePrescribing market size reached USD 1.71 billion in 2023. The rising adaptation of digitalization and technological adoption in healthcare is boosting the growth of the market.
The global clinical data analytics solutions market size was USD 4.75 billion in 2023, calculated at USD 5.07 billion in 2024 and is expected to reach around USD 9.82 billion by 2034, expanding at a CAGR of 6.83% from 2024 to 2034. The rising emphasis on drug development is driving the growth of the market.
The global prescription lens market size was USD 46.28 billion in 2023, calculated at USD 48.77 billion in 2024 and is expected to reach around USD 82.36 billion by 2034, expanding at a CAGR of 5.38% from 2024 to 2034. The North America prescription lens market size reached USD 14.81 billion in 2023 The prescription lens market is driven by the increasing prevalence of astigmatism, hyperopia, and myopia among refractive errors.
The global spinal implants and devices market size was USD 13.40 billion in 2023, calculated at USD 14.16 billion in 2024 and is expected to reach around USD 24.50 billion by 2034, expanding at a CAGR of 5.63% from 2024 to 2034. The North America spinal implants and devices market size reached USD 6.50 billion in 2023. Growing adoption rates due to the advantages of minimally invasive devices including less scarring, faster recovery, and less hospital stay duration, are key drivers of the spinal implants and devices market.
The global omega 3 prescription drugs market size was USD 1.34 billion in 2023, calculated at USD 1.44 billion in 2024 and is expected to reach around USD 2.93 billion by 2034, expanding at a CAGR of 7.37% from 2024 to 2034. The North America omega 3 prescription drugs market size reached USD 590 million in 2023. The rising concerns related to the maintenance of cholesterol levels are also expected to drive the omega 3 prescription drugs market.
The global implantable drug delivery devices market size was USD 12 billion in 2023, calculated at USD 12.63 billion in 2024 and is expected to reach around USD 21 billion by 2034, expanding at a CAGR of 5.12% from 2024 to 2034. The increasing prevalence of chronic diseases globally needs to be tackled at an early stage, creating the urgency to embrace advanced techniques to detect and treat diseases, which are the major factors that are propelling the implantable drug delivery devices market.
The global 3D printed drugs market size was USD 310.80 million in 2023, calculated at USD 338.28 million in 2024 and is expected to reach around USD 789.20 million by 2034, expanding at a CAGR of 8.84% from 2024 to 2034. The North America 3D printed drugs market size reached USD 118.10 million in 2023. The benefits of 3D printed drugs include helping to get novel medicines to patients rapidly. 3D printing is beneficial for patients with rarer conditions, for making bespoke pills with precise dosages, and for delivering personalized medicines to patients’ needs. These factors help to the growth of the market.
The global surgical robot accessories market size was USD 5.32 billion in 2023, calculated at USD 5.80 billion in 2024 and is expected to reach around USD 13.78 billion by 2034. The market is expanding at a solid CAGR of 9.03% over the forecast period 2024 to 2034. The robust growth in healthcare infrastructure to boost the expansion of the market in the coming years.
The global healthcare workforce management system market size was USD 2.10 billion in 2023, calculated at USD 2.28 billion in 2024 and is expected to reach around USD 5.20 billion by 2034, expanding at a CAGR of 8.59% from 2024 to 2034. The healthcare workforce management system market is expected to grow significantly, driven by the shift toward value-based reimbursements and the increasing adoption of telehealth technologies.
The global teledentistry market size was USD 1.52 billion in 2023, calculated at USD 1.75 billion in 2024 and is expected to reach around USD 7.18 billion by 2034. The market is expanding at a solid CAGR of 15.15% over the forecast period 2024 to 2034. The North America teledentistry market size reached USD 550 million in 2023. Teledentistry benefits include reduced fear factors, such as patients experiencing less anxiety because of convenience and reduced need for travel, improved accessibility, such as remote care and communication, making dentistry more accessible, lower costs while still providing quality care, and more precise treatment. These factors help to the growth of the market.
The global psoriatic arthritis treatment market size was USD 11.30 billion in 2023, calculated at USD 12.18 billion in 2024 and is expected to reach around USD 25.89 billion by 2034, expanding at a CAGR of 7.83% from 2024 to 2034. The North America psoriatic arthritis treatment market size reached USD 4.75 billion in 2023. Rising the prevalence of psoriatic arthritis diseases can boost the psoriatic arthritis treatment market.
The global retail clinics market size was USD 5.10 billion in 2023, calculated at USD 5.51 billion in 2024 and is expected to reach around USD 12.04 billion by 2034, expanding at a CAGR of 8.12% from 2024 to 2034. The retail clinics market is growing due to the rising demand for convenient and accessible healthcare services in retail settings.
The global oral transmucosal drugs market size was USD 34.41 billion in 2023, calculated at USD 36.72 billion in 2024 and is expected to reach around USD 70.37 billion by 2034, expanding at a CAGR of 6.72% from 2024 to 2034. The North America oral transmucosal drugs market size reached USD 13.76 billion in 2023. The growth of the oral transmucosal drugs market is attributed to the increasing demand for efficient and rapid drug delivery systems, particularly for medications that require swift absorption into the bloodstream.
The global burn care centers market size was USD 24.08 billion in 2023, calculated at USD 25.10 billion in 2024 and is expected to reach around USD 37.94 billion by 2034, expanding at a CAGR of 4.22% from 2024 to 2034. The North America burn care centers market size reached USD 10.84 billion in 2023. The increasing incidence of trauma cases globally and the hospitalizations related to these are the primary drivers for the burn care centers market.
The global inflammatory bowel disease treatment market size was USD 20.77 billion in 2023, calculated at USD 31.34 billion in 2024 and is expected to reach around USD 31.34 billion by 2034, expanding at a CAGR of 3.81% from 2024 to 2034. The North America inflammatory bowel disease treatment market size was valued at USD 12.25 billion in 2023. The rising prevalence of ulcerative colitis and Crohn's disease across the globe and increasing approval of novel therapeutics are anticipated to drive the inflammatory bowel disease treatment market.
The global dental charting software market size was USD 1.42 billion in 2023, calculated at USD 1.60 billion in 2024 and is expected to reach around USD 5.14 billion by 2034. The market is expanding at a solid CAGR of 12.41% over the forecast period 2024 to 2034. The North America dental charting software market size reached USD 510 million in 2023. The increasing oral health awareness among individuals is fueling the market growth.
The global locum tenens staffing market size was USD 8.83 billion in 2023, calculated at USD 9.5 billion in 2024 and is expected to reach around USD 19.74 billion by 2034, expanding at a CAGR of 7.59% from 2024 to 2034. The North America locum tenens staffing market size reached USD 4.68 billion in 2023. The shortage of healthcare professionals compared to healthcare facilities is driving the growth of the market.
The global respiratory disorders treatment market size was USD 107.50 billion in 2023, calculated at USD 114.05 billion in 2024 and is expected to reach around USD 206.19 billion by 2034, expanding at a CAGR of 6.10% from 2024 to 2034. The rising emphasis on personalized medicine is observed to support the overall expansion of the market.
The global infectious disease molecular diagnostics market size was USD 44.58 billion in 2023, calculated at USD 46.03 billion in 2024 and is expected to reach around USD 63.37 billion by 2034, expanding at a CAGR of 3.25% from 2024 to 2034. The North America infectious disease molecular diagnostics market size reached USD 17.39 billion in 2023. It helps in the identification and detection of infectious agents like parasites, fungi, bacteria, and viruses.
The global cardiology information system market size was USD 1.24 billion in 2023, calculated at USD 1.35 billion in 2024 and is expected to reach around USD 3.26 billion by 2034. The market is expanding at a solid CAGR of 9.20% over the forecast period 2024 to 2034. The North America cardiology information system market size reached USD 410 million in 2023. The rising demand for an efficient software platform for the management of cardiovascular diseases management platform is driving the growth of the market.
The global healthcare finance solutions market size was USD 128.04 billion in 2023, calculated at USD 138.05 billion in 2024 and is expected to reach around USD 293.12 billion by 2034, expanding at a CAGR of 7.82% from 2024 to 2034. The North America healthcare finance solutions market size reached USD 51.22 billion in 2023. The continuous need to improve processes and performance and the requirement for hi-tech equipment and technology are some of the factors driving the healthcare finance solutions market growth.
The global clinical documentation improvement market size was USD 4.52 billion in 2023, calculated at USD 4.88 billion in 2024 and is expected to reach around USD 10.44 billion by 2034, expanding at a CAGR of 7.91% from 2024 to 2034. The North America clinical documentation improvement market size reached USD 1.76 billion in 2023. The rising need for mid-RCM (revenue cycle management) services, management of large amounts of healthcare data, and the widespread adoption of standardized documentation protocols have led to the growth of the clinical documentation improvement market.
The global generic pharmaceuticals contract manufacturing market size was USD 72.50 billion in 2023, calculated at USD 76.73 billion in 2024, and is expected to reach around USD 135.36 billion by 2034, expanding at a CAGR of 5.84% from 2024 to 2034. Asia Pacific dominated the generic pharmaceuticals contract manufacturing market with the largest revenue share of 39% in 2023.
The global bioprocess containers market size was USD 2.44 billion in 2023, calculated at USD 3.08 billion in 2024 and is expected to reach around USD 31.09 billion by 2034. The market is expanding at a solid CAGR of 26.03% over the forecast period 2024 to 2034. The North America bioprocess containers market size reached USD 980 million in 2023. The need for bioprocess containers, which are utilized in the manufacture, storage, and transportation of biopharmaceuticals, is driven by an increase in demand.
The global self-monitoring blood glucose devices market size was USD 10.10 billion in 2023, calculated at USD 11.27 billion in 2024 and is expected to reach around USD 33.30 billion by 2034. The market is expanding at a solid CAGR of 11.63% over the forecast period 2024 to 2034. The North America self-monitoring blood glucose devices market size reached USD 3.94 billion in 2023. The rising number of diabetes patients especially type 2 diabetes drives the growth of the self-monitoring blood glucose devices market.
The global fibrate drugs market size was USD 3.25 billion in 2023, calculated at USD 3.42 billion in 2024 and is expected to reach around USD 5.41 billion by 2033, expanding at a CAGR of 5.22% from 2024 to 2033. The global increase in the prevalence and incidence rate of cardiovascular disorders is anticipated to fuel the fibrate drugs market. The North America fibrate drugs market size reached USD 1.27 billion in 2023.
The global biological buffers market size was USD 749.24 million in 2023, calculated at USD 805.73 million in 2024 and is expected to reach around USD 1,549.96 million by 2033, expanding at a CAGR of 7.54% from 2024 to 2033. The biological buffers market has a variety of products, including biological and pharmaceutical buffers, biochemical-grade buffers, and diagnostic-grade buffers, all of which contribute to its growth and vitality.
The global peptide synthesis market size was USD 581.06 million in 2023, calculated at USD 627.72 million in 2024 and is expected to reach around USD 1257.95 million by 2033, expanding at a CAGR of 8.03% from 2024 to 2033. The benefits of peptide synthesis include it helps to design new vaccines, drugs, and enzymes and is also used to prepare enzyme binding sites, epitope-scientific antibodies, and map antibody epitopes. These factors help to the growth of the market. The North America peptide synthesis market size reached USD 214.99 million in 2023.
The global neurology clinical trials market size was USD 5.58 billion in 2023, calculated at USD 5.89 billion in 2024 and is expected to be worth around USD 9.64 billion by 2033, expanding at a CAGR of 5.62% from 2024 to 2033. The benefits of neurology clinical trials include access to the latest therapies, reduced cost, a chance to help others, closer monitoring, and careful and regular monitoring from the research team that includes healthcare professionals, doctors, and others. These factors help to the growth of the market. The North America neurology clinical trials market size reached USD 2.68 billion in 2023.
The global menstrual health apps market size was USD 1.46 billion in 2023, calculated at USD 1.75 billion in 2024 and is expected to reach around USD 9.04 billion by 2033. The market is expanding at a solid CAGR of 20% over the forecast period 2024 to 2033. The rising health awareness among the women, especially in developing countries is expected to fuel the menstrual health apps market’s growth. The North America menstrual health apps market size reached USD 600 million in 2023.
The global epigenetics diagnostics market size was USD 14.68 billion in 2023, calculated at USD 16.90 billion in 2024 and is expected to reach around USD 60.06 billion by 2033. The market is expanding at a solid CAGR of 15.13% over the forecast period 2024 to 2033. The rising prevalence of chronic diseases, an aging population, and the resulting rising investment in the research and development of epigenetics are driving the epigenetics diagnostics market. The North America epigenetics diagnostics market size reached USD 5.73 billion in 2023.
The global autism spectrum disorder treatment market size was USD 2.21 billion in 2023, calculated at USD 2.35 billion in 2024 and is expected to reach around USD 4 billion by 2033, expanding at a CAGR of 6.12% from 2024 to 2033. The autism spectrum disorder treatment market is driven by the rising diagnosis rates for autism. The North America autism spectrum disorder treatment market size reached USD 1.26 billion in 2023.
The global ECG equipment and management systems market size was USD 7.30 billion in 2023, calculated at USD 7.75 billion in 2024 and is expected to reach around USD 13.23 billion by 2033, expanding at a CAGR of 6.12% from 2024 to 2033. Worldwide cardiovascular disease (CVD) rates are rising, which is driving up demand for echocardiography (ECG) equipment. The ECG equipment and management systems market is crucial in acute and chronic situations because CVDs necessitate ongoing monitoring and diagnosis.
The global oxidative stress assays market size was USD 1.16 billion in 2023, calculated at USD 1.27 billion in 2024 and is expected to reach around USD 2.86 billion by 2033. The market is expanding at a solid CAGR of 9.46% over the forecast period 2024 to 2033. The oxidative stress assay benefits include high output analysis of many small molecule antioxidants and oxidation products from many sample sources like urine, saliva, blood, and blood cells, which will provide a truer and more comprehensive picture of the state of oxidative stress and antioxidant status of the whole body. These factors help to the growth of the market.
The global animal genetics market size was USD 6.11 billion in 2023, accounted for USD 6.50 billion in 2024 and is expected to reach around USD 11.35 billion by 2033, expanding at a CAGR of 6.39% from 2024 to 2033. The animal genetics market is driven by the growing consumer demand for premium proteins.
The global walking assist devices market size was USD 3.96 billion in 2023, calculated at USD 4.21 billion in 2024 and is expected to reach around USD 7.30 billion by 2033, expanding at a CAGR of 6.32% from 2024 to 2033. The rising demand for the mobility solutions for the physically disabled people or injured people with difficulties in walking independently is driving the growth of the walking assist devices market.
The global medical fluid bags market size was USD 3.80 billion in 2023, calculated at USD 4.01 billion in 2024 and is expected to reach around USD 6.50 billion by 2033, expanding at a CAGR of 5.52% from 2024 to 2033. The growing prevalence of chronic diseases globally focuses on health awareness among individuals to drive the growth of the medical fluid bags market.
The global prenatal and newborn genetic testing market size was USD 6.28 billion in 2023, calculated at USD 7.01 billion in 2024 and is expected to reach around USD 18.69 billion by 2033, expanding at a CAGR of 11.52% from 2024 to 2033. The rising prevalence of genetic disorders in infants or newborns is driving the demand for the market.
